NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

SCPH

scPharmaceuticals Inc

Jun 30 • 03:58PM ET

3.81

Dollar change -0.06
Percentage change -1.55	%

Healthcare • Biotechnology • USA • NASD

Peers: AMGN REGN GILD BIIB VRTX NBIX IONS EXEL INCY PBYI

| Held by: VTI IWM VXF IWO VTWO IWC VTWG RSSL IWV QQQS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.91	Insider Own	31.88%	Shs Outstand	50.28M	Perf Week	-0.52%
Market Cap	201.13M	Forward P/E	-	EPS next Y	-0.29	Insider Trans	0.00%	Shs Float	35.96M	Perf Month	7.32%
Enterprise Value	195.95M	PEG	-	EPS next Q	-0.30	Inst Own	56.37%	Short Float	5.08%	Perf Quarter	37.30%
Income	-90.78M	P/S	4.79	EPS this Y	47.02%	Inst Trans	-11.54%	Short Ratio	4.66	Perf Half Y	12.72%
Sales	41.98M	P/B	-	EPS next Y	71.54%	ROA	-107.17%	Short Interest	1.83M	Perf YTD	7.63%
Book/sh	-0.10	P/C	3.50	EPS next 5Y	-	ROE	-934.02%	52W High	5.65 -32.57%	Perf Year	-14.19%
Cash/sh	1.09	P/FCF	-	EPS past 3/5Y	-23.12% -1.52%	ROIC	-193.25%	52W Low	1.94 96.39%	Perf 3Y	-20.63%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	68.64%	Volatility	4.07% 5.63%	Perf 5Y	-54.64%
Dividend TTM	-	EV/Sales	4.67	EPS Y/Y TTM	-28.59%	Oper. Margin	-158.82%	ATR (14)	0.21	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.61	Sales Y/Y TTM	138.10%	Profit Margin	-216.24%	RSI (14)	52.82	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.48	EPS Q/Q	-1.55%	SMA20	-4.55%	Beta	0.37	Target Price	15.60
Payout	-	Debt/Eq	-	Sales Q/Q	92.59%	SMA50	16.00%	Rel Volume	0.50	Prev Close	3.87
Employees	164	LT Debt/Eq	-	Earnings	May 14 AMC	SMA200	8.30%	Avg Volume	391.60K	Price	3.81
IPO	Nov 17, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	-22.31% 1.09%	Trades		Volume	193,739	Change	-1.55%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-07-23	Initiated	Craig Hallum	Buy	$20
Dec-01-22	Initiated	Cowen	Outperform	$25
Oct-21-22	Resumed	Jefferies	Buy	$14
Oct-11-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$11
Aug-02-22	Initiated	Maxim Group	Buy	$10
Sep-09-21	Initiated	SVB Leerink	Mkt Perform	$6
Oct-15-19	Initiated	H.C. Wainwright	Buy	$13
Jan-30-19	Downgrade	Leerink Partners	Outperform → Mkt Perform

May-15-25 09:57AM	Q1 2025 scPharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +28.57%
03:16AM	scPharmaceuticals Inc (SCPH) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion (GuruFocus.com)
May-14-25 05:15PM	ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:01PM	scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
May-13-25 09:43AM	scPharmaceuticals Inc (SCPH) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) -6.45%
08:15AM	Loading…
May-08-25 08:15AM	Insmed (INSM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-07-25 04:01PM	scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025 (GlobeNewswire) +5.24%
May-01-25 04:01PM	scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences (GlobeNewswire)
Mar-21-25 06:32PM	scPharmaceuticals Inc (SCPH) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Mar-20-25 10:18AM	Q4 2024 scPharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
03:03AM	scPharmaceuticals Inc (SCPH) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic ... (GuruFocus.com)
Mar-19-25 07:14PM	ScPharmaceuticals outlines FUROSCIX expansion strategy with CKD launch in April 2025 (SeekingAlpha)
07:13PM	scPharmaceuticals Inc. (SCPH) Q4 2024 Earnings Call Transcript (SeekingAlpha)
05:10PM	ScPharmaceuticals, Inc. (SCPH) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:01PM	scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update (GlobeNewswire)
04:01PM	Loading…
Mar-12-25 04:01PM	scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025 (GlobeNewswire)
Mar-07-25 10:59AM	FDA approves scPharmaceuticals Furoscix sNDA for oedema in CKD (Pharmaceutical Technology) -6.09%
Mar-06-25 04:01PM	scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease (GlobeNewswire)
Mar-05-25 10:00AM	ScPharmaceuticals, Inc. (SCPH) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Feb-26-25 04:01PM	scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences (GlobeNewswire)
Feb-05-25 04:01PM	scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Jan-10-25 08:00AM	scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Nov-14-24 02:15AM	scPharmaceuticals Inc (SCPH) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... (GuruFocus.com) -14.07%
Nov-13-24 05:20PM	ScPharmaceuticals, Inc. (SCPH) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:01PM	scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Nov-06-24 04:01PM	scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024 (GlobeNewswire) +6.63%
Oct-15-24 08:30AM	scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024 (GlobeNewswire)
Sep-04-24 04:05PM	scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-16-24 09:55AM	Does scPharmaceuticals (SCPH) Have the Potential to Rally 291.9% as Wall Street Analysts Expect? (Zacks)
Aug-15-24 11:57AM	Q2 2024 scPharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +5.64%
05:20PM	Loading…
Aug-14-24 05:20PM	ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Aug-12-24 09:48AM	scPharmaceuticals Announces Pricing of $50.0 Million Public Offering (GlobeNewswire)
06:05AM	scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors (GlobeNewswire)
06:04AM	scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX Indication in Heart Failure (GlobeNewswire)
06:02AM	scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 mL) Autoinjector (GlobeNewswire)
06:00AM	scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
Aug-08-24 04:05PM	scPharmaceuticals to Announce Second Quarter 2024 Financial Results on Wednesday, August 14, 2024 (GlobeNewswire) +7.38%
Jul-25-24 08:00AM	scPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (sNDA) Seeking to Expand FUROSCIX Indication to Include Chronic Kidney Disease (GlobeNewswire)
Jul-15-24 11:57AM	7 Short-Squeeze Stocks That Could Beat Down the Bears (InvestorPlace)
Jun-05-24 12:55PM	These 2 Strong Buy Penny Stocks Are Poised for a Massive Rally, Say Analysts (TipRanks) +10.45%
May-29-24 04:01PM	scPharmaceuticals to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-15-24 11:44AM	Q1 2024 scPharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
08:18AM	scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:09AM	scPharmaceuticals Inc (SCPH) (Q1 2024) Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-14-24 08:56PM	SCPH Stock Earnings: scPharmaceuticals Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:20PM	ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:01PM	scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-13-24 04:05PM	scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference (GlobeNewswire)
May-07-24 04:05PM	scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024 (GlobeNewswire)
Apr-24-24 08:00AM	scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection (GlobeNewswire)
Mar-16-24 03:57PM	scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-13-24 05:33PM	scPharmaceuticals Inc (SCPH) Reports Q4 and Full-Year 2023 Financials, Focusing on FUROSCIX Growth (GuruFocus.com)
04:01PM	scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-06-24 04:01PM	scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024 (GlobeNewswire)
Feb-28-24 04:01PM	scPharmaceuticals to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Jan-04-24 04:05PM	scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX Revenue (GlobeNewswire)
Nov-09-23 01:02PM	scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2023 Earnings Call Transcript (Insider Monkey) -8.74%
Nov-08-23 04:01PM	scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-01-23 04:05PM	scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023 (GlobeNewswire)
Oct-31-23 08:00AM	scPharmaceuticals to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Oct-05-23 08:00AM	scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-19-23 08:00AM	scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives (GlobeNewswire)
Sep-05-23 08:00AM	scPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-10-23 05:40PM	ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Aug-03-23 08:00AM	scPharmaceuticals to Announce Second Quarter 2023 Financial Results on Thursday, August 10, 2023 (GlobeNewswire)
Aug-01-23 08:00AM	scPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion (GlobeNewswire)
Jul-19-23 08:00AM	scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-23-23 08:00AM	scPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes (GlobeNewswire)
May-31-23 08:00AM	scPharmaceuticals to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-13-23 12:39PM	scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-12-23 06:03AM	scPharmaceuticals (NASDAQ:SCPH) shareholders have earned a 155% return over the last year (Simply Wall St.)
May-10-23 05:15PM	ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:01PM	scPharmaceuticals Inc. Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-02-23 08:00AM	scPharmaceuticals to Announce First Quarter 2023 Financial Results on Wednesday, May 10, 2023 (GlobeNewswire) +8.74%
Mar-27-23 07:12AM	scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-24-23 06:16AM	When Will scPharmaceuticals Inc. (NASDAQ:SCPH) Turn A Profit? (Simply Wall St.)
Mar-22-23 04:05PM	scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update (GlobeNewswire) +25.14%
Mar-15-23 08:00AM	scPharmaceuticals to Announce Fourth Quarter and Full-Year 2022 Financial Results on Wednesday, March 22 (GlobeNewswire)
Feb-23-23 08:00AM	scPharmaceuticals to Participate in the Cowen 43rd Annual Health Care Conference (GlobeNewswire) +5.31%
Feb-21-23 08:00AM	scPharmaceuticals Announces Launch and Commercial Availability of FUROSCIX® (furosemide injection) (GlobeNewswire) -9.71%
Feb-06-23 08:00AM	scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-31-23 08:00AM	scPharmaceuticals to Participate in the SVB Securities Global Biopharma Conference (GlobeNewswire) +10.55%
Jan-30-23 08:00AM	scPharmaceuticals Provides FUROSCIX® (furosemide injection) Commercial Update (GlobeNewswire)
Jan-10-23 05:37AM	scPharmaceuticals Inc. (NASDAQ:SCPH) stock most popular amongst private equity firms who own 41%, while individual investors hold 36% (Simply Wall St.)
Dec-29-22 06:47PM	scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2022 Earnings Call Transcript (Insider Monkey) +5.78%
Dec-20-22 12:00PM	What Makes scPharmaceuticals, Inc. (SCPH) a New Buy Stock (Zacks)
09:40AM	Has scPharmaceuticals (SCPH) Outpaced Other Medical Stocks This Year? (Zacks)
Dec-19-22 08:00AM	scPharmaceuticals Inc. Announces Appointment of Rachael Nokes as Chief Financial Officer (GlobeNewswire)
Dec-14-22 08:00AM	scPharmaceuticals to Participate in the 12th Annual LifeSci Partners Corporate Access Event (GlobeNewswire)
Nov-22-22 08:01AM	scPharmaceuticals Announces Pricing of $50 Million Public Offering (GlobeNewswire) +14.45%
Nov-21-22 04:01PM	scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock (GlobeNewswire)
Nov-09-22 04:30PM	Edited Transcript of SCPH.OQ earnings conference call or presentation 9-Nov-22 9:30pm GMT (Thomson Reuters StreetEvents) +12.27%
04:05PM	scPharmaceuticals Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Nov-02-22 08:00AM	scPharmaceuticals to Participate in the Jefferies London Healthcare Conference (GlobeNewswire)
Oct-26-22 08:00AM	scPharmaceuticals to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 9, 2022 (GlobeNewswire) +5.84%
Oct-11-22 05:32PM	scPharmaceuticals (SCPH) Plunges Despite Furoscix's FDA Approval (Zacks) +39.30%
Oct-10-22 09:41AM	UPDATE - scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide injection), the First and Only Self-administered, Subcutaneous Loop Diuretic for the At-home Treatment of Congestion in Chronic Heart Failure (GlobeNewswire) -19.28%
09:24AM	FDA Approves scPharmaceuticals' Self-Administered Med For Congestion in Chronic Heart Failure (Benzinga)

scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SCHAEFFER LEONARD D	Director	Aug 26 '24	Option Exercise	2.58	11,347	29,308	54,451	Aug 28 04:30 PM
ORBIMED ADVISORS LLC	10% Owner	Aug 13 '24	Buy	4.00	500,000	2,000,000	5,806,670	Aug 15 04:51 PM
Nokes Rachael	CFO and Treasurer	Aug 06 '24	Option Exercise	0.00	10,445	0	72,851	Aug 08 04:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SCPH

scPharmaceuticals Inc

Upgrade your FINVIZ experience